BlackRock Inc. - XERIS BIOPHARMA HOLDINGS INC ownership

XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 104 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of XERIS BIOPHARMA HOLDINGS INC
ValueSharesWeighting
Q3 2023$17,436,089
-28.7%
9,374,242
+0.4%
0.00%0.0%
Q2 2023$24,456,642
+78.3%
9,334,596
+11.0%
0.00%
Q1 2023$13,713,483
+20.2%
8,413,180
-1.9%
0.00%
Q4 2022$11,406,362
-11.2%
8,576,213
+4.2%
0.00%
Q3 2022$12,838,000
+4.1%
8,228,628
+2.8%
0.00%
Q2 2022$12,331,000
+141.5%
8,006,794
+301.4%
0.00%
Q1 2022$5,107,000
-2.9%
1,994,879
+11.1%
0.00%
Q4 2021$5,261,0001,795,5130.00%
Other shareholders
XERIS BIOPHARMA HOLDINGS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAXTON CORP 6,039,028$9,843,61624.86%
Stonepine Capital Management, LLC 8,640,205$14,083,5344.72%
Alpine Global Management, LLC 400,000$652,0000.25%
DELTEC ASSET MANAGEMENT LLC 622,072$1,013,9770.25%
XTX Topco Ltd 233,385$380,4180.08%
Redmile Group, LLC 1,046,587$1,705,9370.07%
GSA CAPITAL PARTNERS LLP 316,025$5150.05%
Yakira Capital Management, Inc. 90,076$146,8240.04%
IHT Wealth Management, LLC 281,442$458,7620.03%
TUDOR INVESTMENT CORP ET AL 960,111$1,5650.02%
View complete list of XERIS BIOPHARMA HOLDINGS INC shareholders